- Home
- TGB vs BCRX Comparison
TGB vs BCRX Comparison
Compare TGB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGB
- BCRX
- Stock Information
- Founded
- TGB 1966
- BCRX 1986
- Country
- TGB Canada
- BCRX United States
- Employees
- TGB N/A
- BCRX N/A
- Industry
- TGB Precious Metals
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TGB Basic Materials
- BCRX Health Care
- Exchange
- TGB Nasdaq
- BCRX Nasdaq
- Market Cap
- TGB 1.6B
- BCRX 1.4B
- IPO Year
- TGB N/A
- BCRX 1994
- Fundamental
- Price
- TGB $4.36
- BCRX $6.99
- Analyst Decision
- TGB Hold
- BCRX Strong Buy
- Analyst Count
- TGB 1
- BCRX 11
- Target Price
- TGB $5.00
- BCRX $19.00
- AVG Volume (30 Days)
- TGB 6.9M
- BCRX 7.8M
- Earning Date
- TGB 10-31-2025
- BCRX 11-03-2025
- Dividend Yield
- TGB N/A
- BCRX N/A
- EPS Growth
- TGB N/A
- BCRX N/A
- EPS
- TGB N/A
- BCRX N/A
- Revenue
- TGB $424,271,553.00
- BCRX $599,816,000.00
- Revenue This Year
- TGB $11.04
- BCRX $41.57
- Revenue Next Year
- TGB $48.69
- BCRX $6.25
- P/E Ratio
- TGB N/A
- BCRX N/A
- Revenue Growth
- TGB N/A
- BCRX 45.38
- 52 Week Low
- TGB $1.67
- BCRX $6.00
- 52 Week High
- TGB $4.84
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- TGB 55.71
- BCRX 45.03
- Support Level
- TGB $4.16
- BCRX $6.51
- Resistance Level
- TGB $4.58
- BCRX $7.22
- Average True Range (ATR)
- TGB 0.19
- BCRX 0.28
- MACD
- TGB -0.00
- BCRX 0.02
- Stochastic Oscillator
- TGB 74.73
- BCRX 48.44
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.